Results 21 to 30 of about 11,965 (161)

Effect of genetic polymorphism on individualized treatment of tacrolimus in patients with primary nephrotic syndrome

open access: yesLinchuang shenzangbing zazhi, 2021
As a highly effective immunosuppressant, tacrolimus(TAC,FK506)has been widely applied for primary nephrotic syndrome.However, excessive dose or underexposure of TAC remains rampant in clinical practices.Recent studies have indicated that cytochrome P450 ...
Xiong Lian-lian, Yi Bin
doaj  

Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells [PDF]

open access: yes, 2020
Background/Aims: Orthotopic liver transplantation (OLT) is the recommended treatment for patients at early stages of hepatocarcinoma (HCC) with portal hypertension and/or increased bilirubinemia, but without vascular-associated diseases.
Muntané Relat, Jordi   +12 more
core   +1 more source

Action of tacrolimus on Wistar rat kidneys implanted with Walker 256 carcinosarcoma Estudo da ação do tacrolimus em rins de ratos Wistar implantados com carcinossarcoma de Walker

open access: yesActa Cirúrgica Brasileira, 2010
PURPOSE: To evaluate the development of Walker 256 tumor in male Wistar rats treated with tacrolimus using an experimental kidney tumor model. METHODS: 40 male Wistar rats were divided into four groups: Tumor group (TU) (n=10), Tacrolimus-Tumor group (TT)
Cristiano Machado Inácio   +6 more
doaj   +1 more source

Cyclophilin nomenclature problems, or, 'a visit from the sequence police'

open access: yesHuman Genomics, 2004
Why is agreement on one particular name for each gene important? As one genome after another becomes sequenced, it is imperative to consider the complexity of genes, genetic architecture, gene expression, gene-gene and gene-product interactions and ...
Nebert Daniel W   +3 more
doaj   +1 more source

FK506 biosynthesis is regulated by two positive regulatory elements in Streptomyces tsukubaensis

open access: yesBMC Microbiology, 2012
Background FK506 (Tacrolimus) is an important immunosuppressant, produced by industrial biosynthetic processes using various Streptomyces species.
Goranovič Dušan   +14 more
doaj   +1 more source

Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: Role of glutamate uptake and FK506 binding protein 12 kDa

open access: yesNeuroscience, 2006
The mechanisms underlying the neuroprotective effects of the immunosuppressant tacrolimus, observed in vivo, remain unclear. Here we quantify these effects in vitro, and evaluate the potential involvement of the glutamate and/or immunophilin FK506 binding protein 12 kDa in tacrolimus-induced neuroprotection.Primary cultures of neurons and astrocytes ...
Labrande, Christelle   +6 more
openaire   +3 more sources

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

open access: yes, 2001
Tacrolimus is a potent immunosuppressive agent used to prevent allograft rejection. The pharmacokinetics of tacrolimus have been studied in healthy volunteers and transplant recipients, mostly by using immunoassays to measure tacrolimus in plasma or ...
Wallemacq, Pierre, Verbeeck, Roger-K.
core   +1 more source

Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival

open access: yesAdvanced Science, EarlyView.
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang   +14 more
wiley   +1 more source

Study of the Change Factors of Tacrolimus Consentration in Serum : From Viewpoint of Serum Protein Binding

open access: yes, 2005
P(論文)Tacrolimus (FK506), which is a potent imuunosuppressive drug, has the excellent effect for prevention of rejection after on organ transu;oanttation.
本屋, 敏郎   +56 more
core   +2 more sources

Home - About - Disclaimer - Privacy